What Nexalin Technology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hu Ben | Director | Sep 29 | Grant / award · A | +36,459 | — | — | 377,095 |
| Kazden Alan | Director | Sep 29 | Grant / award · A | +36,459 | — | — | 119,590 |
| Owens David | Chief Medical Officer | Sep 29 | Grant / award · A | +36,459 | — | — | 191,252 |
| Osser Leonard | 10% owner | Sep 29 | Grant / award · A | +83,333 | — | — | 1,618,577 |
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Mar 12 | Open-market buy · P | +6,000 | $2.20 | +$13.2K | 30,000 |
| Owens David | Chief Medical Officer | Feb 04 | Open-market buy · P | +1,000 | $3.10 | +$3.1K | 155,793 |
| Owens David | Chief Medical Officer | Feb 04 | Open-market buy · P | +1,000 | $2.98 | +$2.98K | 154,793 |
| Owens David | Chief Medical Officer | Jan 28 | Open-market buy · P | +1,500 | $2.70 | +$4.05K | 153,793 |
| Owens David | Chief Medical Officer | Jan 23 | Open-market buy · P | +1,000 | $2.70 | +$2.7K | 152,293 |
| Owens David | Chief Medical Officer | Jan 13 | Open-market buy · P | +2,000 | $2.50 | +$5K | 151,293 |
| Owens David | Chief Medical Officer | Dec 20 | Open-market buy · P | +1,000 | $2.75 | +$2.75K | 149,293 |
| Owens David | Chief Medical Officer | Oct 28 | Open-market buy · P | +500 | $2.19 | +$1.1K | 148,293 |
| Shelton Carolyn Hamby | Senior VP | Oct 14 | Open-market buy · P | +24,000 | $0.85 | +$20.4K | 24,000 |
| Bernhard Leslie | Director | Sep 30 | Grant / award · A | +49,838 | — | — | 49,838 |
| Hu Ben | Director | Sep 30 | Grant / award · A | +175,000 | — | — | 340,636 |
| Elson Marilyn | 10% owner | Sep 30 | Grant / award · A | +700,000 | — | — | 1,535,244 |
| Elson Marilyn | 10% owner | Sep 23 | Grant / award · A | +700,000 | — | — | 1,535,244 |
| Owens David | Chief Medical Officer | Aug 13 | Open-market buy · P | +1,000 | $0.95 | +$950 | 147,793 |
| Owens David | Chief Medical Officer | Jun 28 | Open-market buy · P | +1,000 | $1.75 | +$1.75K | 146,793 |
| Owens David | Chief Medical Officer | Jun 18 | Open-market buy · P | +1,619 | $0.71 | +$1.15K | 145,793 |
Loading...
